Evaluation of resistance to activated protein C in patients suffering from myocardial infarction;Valutazione della resistenza alla proteina C attivata in soggetti con pregresso IMA

Minerva Cardioangiologica

Volumn 49, Issue 6, 2001, Pages 363-368

  Avellone, G ^a   Di Garbo, V ^a   Di Raimondo, D ^a   Bono, M ^a   Abruzzese, G ^a   De Simone, R ^a   Raneli, G ^a  

^a NONE

Author keywords

Activated protein C resistance, diagnosis; Myocardial infarction, diagnosis; Risk factors; Thrombosis

Indexed keywords

ACTIVATED PROTEIN C RESISTANCE; ADULT; ARTICLE; HEART INFARCTION; HUMAN; MALE; PREVALENCE;

ACTIVATED PROTEIN C RESISTANCE; ENGLISH ABSTRACT; HUMAN; MALE; MIDDLE AGE; MYOCARDIAL INFARCTION; PREVALENCE;

EID: 0035656991     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:113-4.
2. Bertina RM, Koeleman BPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994;369:64-7.
3. Dahlback B. Inherited thrombophilia: resistance to activated protein C as a pathogenetic factor of venous thromboembolism. Blood 1995;85:607-14.
4. Laffan MA. Activated Protein C resistance and myocardial infarction. Heart 1998;80:319-21.
5. Avellone G, Di Garbo V, Cordova R. Emostasi e flebopatie. Minerva Angiol 1992;2(S1):25-7.
6. Ferrari E, Baudouy M, Cerboni P, Tibi T, Fuigner A, Leonetti J et al. Clinical epidemiology of venous thromboembolic disease. Eur Heart J 1997;18:685-91.
7. Mannucci PM. Una nuova causa di trombofilia. Ann Ital Med Int 1996;11:5-7.
8. Ridker PM, Hennekens CH, Lindpaintner K, Stampfer MJ, Eisenberg PR, Miletich JP. Mutation in the gene coding for coagulation factor V and the risk of myocarclial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995;332:912-73.
9. Rosendaal FR. Venous thrombosis, a multicausal disease. Lancet 1999;353:1167-73.
10. Panzini E, Raffa S, Miconi R, Lozzi A, Marci M. Anticoncezionali orali e resistenza alla proteina C attivata: esempio paradigmatico delle interazioni tra genotipo e ambiente nello sviluppo della trombosi venosa profonda. Clin Ter 1999;150:445-7.
11. Rosendaal FR, Siscovick DS, Schwartz SM, Beverly RK, Psaty BM, Longstreth WT. Factor V Leiden (Resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood 1997;89:2817-21.
12. Doggen CJM, Manger Cats V, Bertina RM, Rosendaal FR. Interaction of coagulation and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden of Prothrombin 20210A. Circulation 1998;97:1037-41.
13. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larson B, Tibblin G. Fibrinogen as risk factor for stroke and myocardial infarotion. N Engl J Med 1984;311:501-5.
14. Folsom AR, Wu KK, Shahar E, Davis CE. Association of hemoslatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb 1993;13:1829-36.
15. Holvoet P, Vanhaecke J, Janssens S, van der Werf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes or stable coronary disease. Circulation 1998;98:1487-94.
16. Avellone G, Di Garbo V, Cordova R. La sindrome trombofilica nelle vasculopatie periferiche. Minerva Angiol 1993;1(S1):207-9.
17. Miletich JP. Thrombophilia as a multigenic disorder. Semin Thromb Hemost 1998;24(Suppl 1):13-20.
18. Martinelli I, Bottasso B, Duca F, Faioni E, Mannucci PM. Heightened thrombin generation in individuals with resistance to activated protein C. Thromb Haemost 1996;75:703-5.
19. Ardissino D, Peyvardi F, Nerlini Pa, Colombi E, Mannucci PM. Factor V (Arg506→Gln) mutation in young survivors of myocardial infarction. Thromb Haemost 1996;75:701-2.
20. Holm J, Zoller B, Svensson PJ, Berntorp E, Erhardt L, Dahlback B. Myocardial infarction associated with homozygous resistance to activated protein C. Lancet 1994;344:952-3.
21. Moia M, La Spina I, Paladino R, Carpenedo M. Mutazione Arg506→Gln del fattore V della coagulazione (fattore V Leiden) ed ischemia cerebrale transitoria in giovane età in tre membri della stessa famiglia. Ann Ital Med Int 1996;11:17-9.
22. Van der Bom BJ, Bots ML, Haverkate F, Slagboom PE, Meijr P, de Tong PT et al. Reduced response to activated protein C is associated with increased risk for cerebrovascular disease. Ann Intern Med 1996;125:265-9.
23. Dacosta A, Tardy-Poncet B, Isaaz K, Cerisier A, Mismetti P, Simitsidis S et al. Prevalence of factor V Leiden (APCR) and other inherited trombophilias in young patients with myocardial infarction and normal coronary arteries. Heart 1998;80:338-40.